Pharma News: VIVUS, Inc. (VVUS) Qsymia Patents, Arena Pharmaceuticals, Inc. (ARNA) Earnings, Amgen, Inc. (AMGN) Ending an Agreement

Edito’s Note:  VIVUS, Inc. (NASDAQ:VVUS),  Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN)

VIVUS, Inc. (NASDAQ:VVUS)VIVUS QSYMIA PATENTS: APPEARANCE OF ONGOING AND SYSTEMATIC INEQUITABLE CONDUCT BEFORE THE USPTO (World News Report)
Earlier today RFD IP Business Services (“RFD”) released a new report analyzing the likely inequitable conduct challenges to VIVUS, Inc. (NASDAQ:VVUS) and the patents that protect its approved drug, Qsymia(R) (fixed dose combinations of phentermine and topiramate). What is new in the Inequitable Conduct Report? The report exposes the tension between, on the one hand, admissions by Vivus attorneys at Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo PC (“Mintz Levin”) that the company’s earliest Qsymia patents do not teach how to use low doses of topiramate (15 to 50 mg), while simultaneously trying to obtain claims from these early patents that cover doses of topiramate from 5 to 1000 mg.

News Buzz: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Pandora Media Inc (NYSE:P) (SBWire)
Earnings of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the second quarter of 2013 at 17 cents per share were higher than the earnings in the previous year. The firm’s revenues of $68.9 million were 213% higher than the previous year for the same period thanks to $65 million milestone payment from partner Eisai for Belviq. The pharmaceutical firm had launched the obesity drug, Belviq in June 2013 and the drug has recorded sales of $1.3 million which is evident from the 12,500 prescriptions written for it until July 19. The firm also got $0.5 million milestone payment from Eisai submission of New Drug in Canada for Belviq.

Array says Amgen ends agreement, to cut 20 percent jobs (Reuters)
Array Biopharma said it would cut 20 percent of its workforce as  Amgen, Inc. (NASDAQ:AMGN) plans to end an agreement to develop and market Array’s drug to treat Type 2 diabetes. Array shares fell as much as 7 percent to $6.12 in trading after the bell. The company said it would record a one-time restructuring charge of $2.7 million in the first quarter of fiscal 2014. Array and  Amgen, Inc. (NASDAQ:AMGN) entered into the agreement in December 2009, under which Array received an upfront payment of $60 million and milestone payments of $8.5 million.

Amgen ‘neck and neck’ with competitors in race for new anti-cholesterol drugs approval (Med City News)
In one of the most closely-watched medical races of all time, Amgen and rival pharmaceutical companies are chasing approval for new anti-cholesterol drugs that have the potential to be blockbusters. Cardiologists see them as the single most promising class of drugs currently in development, said Dr. Steven Nissen, the department chair of cardiovascular medicine at the Cleveland Clinic. For its new cholesterol-fighting drug, AMG 145, Thousand Oaks-based Amgen expects to have data from its pre-marketing clinical trial period available in early 2014.

2 Biotechs Aim To Capitalize On The Treatment Of Melanoma (Seeking Alpha)
Data from key trials of experimental treatments for melanoma brings good news for those affected by this deadly form of cancer. Following the disappointment from Vical’s (VICL) failed Phase 3 study, the development of melanoma treatments offer investors a solid opportunity with two different stocks.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!